簡易檢索 / 詳目顯示

研究生: 林子期
Lin, Tzu-Chi
論文名稱: O-Tosyl Amidoximes及Aryl Oxadiazolones與 3-Dimethylaminopropenones經由[3 + 2]環加成反應得到 2,4-Disubstituted Imidazoles之合成研究
Synthetic Studies of the 2,4-Disubstituted Imidazoles via [3 + 2] Cycloaddition Reaction of O-Tosyl Amidoximes and Aryl Oxadiazolones with 3-Dimethylaminopropenones
指導教授: 簡敦誠
Chien, Tun-Cheng
學位類別: 碩士
Master
系所名稱: 化學系
Department of Chemistry
論文出版年: 2020
畢業學年度: 108
語文別: 中文
論文頁數: 25
中文關鍵詞: 金屬鹽[3+2]環加成反應咪唑(Imidazole)
英文關鍵詞: O-tosyl alkyl amidoxime, aryl oxadiazolone, iron(III)-catalyzed [3+2] cycloaddition
DOI URL: http://doi.org/10.6345/NTNU202000042
論文種類: 學術論文
相關次數: 點閱:67下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 研究O-tosyl alkyl amidoximes與3-dimethylaminopropenone derivatives於適當金屬鹽條件下進行[3+2]環加成反應。O-tosyl alkyl amidoximes 可以由alkyl nitriles與hydroxylamine進行親核加成反應得到alkyl amidoximes,而alkyl amidoximes接著與TsCl進行O-tosylation得到。同時,3-dimethylaminopropenones可以由methyl ketones與N,N-dimethylforamide-dimethylacetal (DMF-DMA)進行反應得到。不幸地,O-tosyl aryl amidoximes不能以相同步驟被製備。找尋另一替代方式,發現oxadiazolones可以進行[3+2]環加成反應,而其可以由aryl oximes與carbonylimidazole (CDI)進行兩次親核加成與消去反應所製備。我們的研究顯示出以O-tosyl alkyl amidoximes及aryl oxadiazolones作為反應物,與3-dimethylaminopropenones進行[3+2]環加成反應,可以作為一新穎的方式得到4-acyl-2-substituted imidazoles。

    A systematic screening of metal ion catalysts for the [3+2] cycloaddition of O-tosyl alkyl amidoximes with 3-dimethylaminopropenone derivatives was studied. O-Tosyl alkyl amidoximes can be obtained by nucleophilic addition of hydroxylamine to alkyl nitriles followed by tosylation with TsCl. Meanwhile, 3-dimethylaminopropenones were obtained from the reaction of methyl ketones with N,N-dimethylformamide-dimethylacetal. Unfortunately, O-tosyl aryl amidoximes cannot be obtained by the same process. Alternatively, aryl oxadiazolones were obtained by nucleophilic addition and elimination of aryl oximes to carbonyldiimidazole. Our investigation showed that iron(III)-catalyzed [3+2] cycloaddition of O-tosyl alkyl amidoximes and aryl oxadiazolones with 3-dimethylaminopropenones can serve as a novel approach toward 4-acyl-2-substituted imidazoles.

    目錄 I 試劑縮寫對照表 II Abstract III 中文摘要 IV 第一章 緒論 1 第二章 文獻回顧 7 參考文獻 22

    [1]. M. R. Grimmett Imidazole and benzimidazole synthesis; Academic press, 1997.
    [2]. R. Sivek; Pytela, O.; Bureš, F. J. Heterocycl. Chem. 2008, 45, 1621.
    [3]. S. Kamijo; Yamamoto, Y. Chem Asian J 2007, 2, 568.
    [4]. A. D. Palkowitz; Steinberg, M. I.; Thrasher, K. J.; Reel, J. K.; Hauser, K. L.; Zimmerman, K. M.; Wiest, S. A.; Whitesitt, C. A.; Simon, R. L. J. Med. Chem. 1994, 37, 4508.
    [5]. L. Labanauskas; Brukštus, A.; Gaidelis, P.; Buchinskaite, V.; Udrenaite, E.; Daukšas, V. Pharm. Chem. J. 2000, 34, 353.
    [6]. J. C. Lee; Laydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M. J.; Keys, J. R.; Strickler, J. E. Nature 1994, 372, 739.
    [7]. G. J. Atwell; Fan, J.-Y.; Tan, K.; Denny, W. A. J. Med. Chem. 1998, 41, 4744.
    [8]. M. Boiani; González, M. Mini-Rev. Med. Chem. 2005, 5, 409.
    [9]. B. Zingales Acta trop. 2018, 184, 38.
    [10]. D. Scholz; Billich, A.; Charpiot, B.; Ettmayer, P.; Lehr, P.; Rosenwirth, B.; Schreiner, E.; Gstach, H. J. Med. Chem. 1994, 37, 3079.
    [11]. H. Ahmed; Abushouk, A. I.; Attia, A.; Gadelkarim, M.; Gabr, M.; Negida, A.; Abdel-Daim, M. M. J. Infect. Public Health 2018, 11, 156.
    [12]. R. Sevak; Paul, A.; Goswami, S.; Santani, D. Pharmacol. Res. 2002, 46, 351.
    [13]. S. Graßmann; Sadek, B.; Ligneau, X.; Elz, S.; Ganellin, C. R.; Arrang, J.-M.; Schwartz, J.-C.; Stark, H.; Schunack, W. Eur. J. Pharm. Sci. 2002, 15, 367.
    [14]. C. D. Freeman; Klutman, N. E.; Lamp, K. C. Drugs 1997, 54, 679.
    [15]. R. Brimblecombe; Duncan, W.; Durant, G.; Emmett, J.; Ganellin, C.; Parsons, M. J. Int. Med. Res. 1975, 3, 86.
    [16]. A. Marek; Kulhanek, J.; Ludwig, M.; Bures, F. Molecules 2007, 12, 1183.
    [17]. J.-S. You; Yu, X.-Q.; Xiang, Q.-X.; Lan, J.-B.; Xie, R.-G.; Zhang, G.-L. Chem. Commun. 2001, 1816.
    [18]. N. V. Plechkova; Seddon, K. R. Chem. Soc. Rev. 2008, 37, 123.
    [19]. 亚. 汪 Pharmacy Information 2019, 08, 43.
    [20]. A. C. Cole; Jensen, J. L.; Ntai, I.; Tran, K. L. T.; Weaver, K. J.; Forbes, D. C.; Davis, J. H. J. Am. Chem. Soc. 2002, 124, 5962.
    [21]. 万. 骆 Journal of Advances in Physical Chemistry 2012, 01, 7.
    [22]. 陈佳萍; 吴昌松; 施梓宇; 李梦倩; 贾志舰; 王灵辉 合成化学 2018, 26, 364.
    [23]. K. Ebel; Koehler, H.; Gamer, A. O.; Jäckh, R. In Ullmann's Encyclopedia of Industrial Chemistry 2000.
    [24]. Erner, W. E. (1958). U.S. Patent No. 2,847,417. Washington, DC: U.S. Patent and Trademark Office.
    [25]. Adams, J. L., Gallagher, T. F., Lee, J. C., & White, J. R. (1997). U.S. Patent No. 5,686,455. Washington, DC: U.S. Patent and Trademark Office
    [26]. D. Tang; Wu, P.; Liu, X.; Chen, Y. X.; Guo, S. B.; Chen, W. L.; Li, J. G.; Chen, B. H. J. Org. Chem. 2013, 78, 2746.
    [27]. X. Liu, D. Wang, B. Chen Tetrahedron 2013, 69, 9417.
    [28]. C. C. Lin; Hsieh, T. H.; Liao, P. Y.; Liao, Z. Y.; Chang, C. W.; Shih, Y. C.; Yeh, W. H.; Chien, T. C. Org. Lett. 2014, 16, 892.
    [29]. B. H. James; Henderson, S. A. D.; Google Patents: 1945.
    [30]. U. S. Mahajan; Godinde, R. R.; Mandhare, P. Synth. Commun. 2011, 41, 2195.
    [31]. Y.-X. Xie and J. Wang, Chem. Commun. 2018, 54, 4597–4600
    [32]. J.-P. Qu, P. Wu, D. Tang, X. Meng, Y.-X. Chen, S. Guoab, and B. Chen, New J. Chem. 2015, 39, 4235–4239
    [33]. M. Y. Stevens; Rozycka-Sokolowska, E.; Andersson, G.; Odell, L. R.; Marciniak, B.; Joule, J. A. ARKIVOC 2015, 219.
    [34]. X. Liu; Fu, H.; Jiang, Y.; Zhao, Y. Angew. Chem. Int. Ed. 2009, 48, 348.
    [35]. B. Li; Samp, L.; Sagal, J.; Hayward, C. M.; Yang, C.; Zhang, Z. J. Org. Chem. 2013, 78, 1273.
    [36]. J. Zhou; Fu, L.; Lv, M.; Liu, J.; Pei, D.; Ding, K. Synthesis 2008, 2008, 3974.
    [37]. X. Yu; Chen, K.; Yang, F.; Zha, S.; Zhu, J. Org. Lett. 2016, 18, 5412.
    [38]. 陳盈成,國立臺灣師範大學碩士論文,107年
    [39]. B. Movassagh; Talebsereshki, F. Synth. Commun. 2014, 44, 188.
    [40]. T. Shimbayashi; Okamoto, K.; Ohe, K. Synlett 2014, 25, 1916.
    [41]. Z. Zeng; Jin, H.; Xie, J.; Tian, B.; Rudolph, M.; Rominger, F.; Hashmi, A. S. K. Org. Lett. 2017, 19, 1020.
    [42]. F. Tiemann, B. Dtsch. Chem. Ges. 1891, 24, 4162.
    [43]. J. Pinnow, B. Dtsch. Chem. Ges. 1891, 24, 4167.
    [44]. C.-H. Wang; Hsieh, T.-H.; Lin, C.-C.; Yeh, W.-H.; Lin, C.-A.; Chien, T.-C. Synlett 2015, 26, 1823.
    [45]. M. Partridge; Turner, H. J. Pharm. Pharmacol. 1953, 5, 103.
    [46]. Y. Yamamoto; Tsuritani, T.; Mase, T. Tetrahedron 2008, 49, 876.
    [47]. T. H. Hsieh; Liao, P. Y.; Liu, Y. T.; Wang, C. H.; Lin, C. C.; Chien, T. C. J. Chin. Chem. Soc. 2018, 65, 325.
    [48]. C. D. d. C. Alves, 2018.
    [49]. C. O'Brien Chem. Rev. 1964, 64, 81.
    [50]. M. Rens; Ghosez, L. Tetrahedron 1970, 11, 3765.
    [51]. G. De Voghel; Eggerichs, T.; Clamot, B.; Viehe, H. Chimia 1976, 30, 191.
    [52]. J. A. Hyatt J. Org. Chem. 1981, 46, 3953.
    [53]. A. Tam; Armstrong, I. S.; La Cruz, T. E. Org. Lett. 2013, 15, 3586.
    [54]. J.-M. Stutzmann; Bohme, G. A.; Boireau, A.; Damour, D.; Debono, M. W.; Genevois-Borella, A.; Imperato, A.; Jimonet, P.; Pratt, J.; Randle, J. C. Bioorg. Med. Chem. Lett. 2000, 10, 1133.
    [55]. M. Vuilhorgne; Malpart, J.; Mutti, S.; Mignani, S. J. Heterocycl. Chem. 2003, 40, 159.
    [56]. T. Canton; Böhme, G. A.; Boireau, A.; Bordier, F.; Mignani, S.; Jimonet, P.; Jahn, G.; Alavijeh, M.; Stygall, J.; Roberts, S. J. Pharmacol. Exp. Ther. 2001, 299, 314.
    [57]. J. J. Baldwin; Christy, M. E.; Denny, G. H.; Habecker, C. N.; Freedman, M. B.; Lyle, P. A.; Ponticello, G. S.; Varga, S. L.; Gross, D. M.; Sweet, C. S. J. Med. Chem. 1986, 29, 1065.
    [58]. N. Kudo; Furuta, S.; Taniguchi, M.; Endo, T.; Sato, K. Chem. Pharm. Bull. 1999, 47, 857.
    [59]. S. Liu; Premnath, P. N.; Bolger, J. K.; Perkins, T. L.; Kirkland, L. O.; Kontopidis, G.; McInnes, C. J. Med. Chem. 2013, 56, 1573.
    [60]. R. C. Reid; Yau, M.-K.; Singh, R.; Hamidon, J. K.; Lim, J.; Stoermer, M. J.; Fairlie, D. P. J. Med. Chem. 2014, 57, 8459.
    [61]. P. S. Branco; Prabhakar, S.; Lobo, A. M.; Williams, D. J. Tetrahedron 1992, 48, 6335.

    無法下載圖示 電子全文延後公開
    2025/12/31
    QR CODE